期刊文献+

一氧化氮供体型药物抗肿瘤作用的研究进展 被引量:1

Progress in the Study of Anti-tumor Effect of Nitric Oxide Donor Drugs
下载PDF
导出
摘要 肿瘤已经成为当今社会的重大健康问题,作为抗肿瘤药物的一氧化氮(NO)供体型药物在这方面引人注目。一些NO供体药物已被证明具有良好的抗癌活性,显示出其应用潜力和价值。通过控制NO在适当的部位释放并杀死肿瘤细胞,实现药物的靶向性,是NO供体类药物治疗癌症的一个新领域和重要的发展方向。本文将综述NO供体型药物在抗肿瘤领域的研究进展,以及简要介绍新型NO供体纳米材料。 Tumor has become a major health problem in today's society.As an anti-tumor drug,nitric oxide(NO)donor drug has attracted much attention in this field.Some NO donor drugs have shown good anti-cancer activity,showing their potential applications and value.It is a new field and an important development direction for NO donors to treat cancer by controlling the release of NO in appropriate sites and killing tumor cells,and then achieving drug targeting.This paper reviewed the research progress of NO donor drug-based drugs in the field of anti-tumor,and briefly introduce the new NO donor nanoparticle materials.
作者 宾雨飞 廖端芳 BIN Yufei;LIAO Duanfang(School of Pharmacy,Hunan University of Chinese Medicine,Changsha,Hunan 410208,China;Key Laboratory in Hunan Province for Quality Evaluation of Bulk Medicinal Materials from Hunan Province,Changsha,Hunan 410208,China)
出处 《湖南中医药大学学报》 CAS 2019年第5期663-669,共7页 Journal of Hunan University of Chinese Medicine
基金 湖南省自然科学基金(2015JJ6085)
关键词 肿瘤 NO供体型药物 新型NO供体纳米材料 tumor nitric oxide donor drugs new nitric oxide donor nanoparticle materials
  • 相关文献

参考文献4

二级参考文献33

  • 1邓艳君,石静波,姜力勋,高静,姚其正.嘧啶并呋咱核苷衍生物的制备及其活性初探[J].化学学报,2006,64(18):1911-1915. 被引量:10
  • 2Seabra AB, De Lima R, Calder6n M. Nitric oxide releasing nanoma-terials for cancer treatment: current status and perspectives[ J]. Curr Top Med Chem, 2015, 15(4) : 298-308.
  • 3Carradori S, Mollica A, De Monte C, et al. Nitric oxide donors and selective carbonic anhydrase inhibitors: a dual pharmacological approach for the treatment of glaucoma, cancer and osteoporosis [ J ]. Molecules, 2015, 20 ( 4 ) : 5667-5679. DOI: 10. 3390/mole- cules20045667.
  • 4Reynolds MM, Witzeling SD, Damodaran VB, et al. Applications for nitric oxide in halting proliferation of tumor cells [ J ]. Biochem Bio- phys Res Commun, 2013, 431 (4): 647-651. DOI: 10. 1016/j. bbrc. 2013.01. 041.
  • 5Hagen T, Taylor CT, Lam F, et al. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1 atpha[ J ]. Science, 2003, 302 (5652) : 1975-1978. DOI : 10.1126/science. 1088805.
  • 6Cheng H, Wang L, Mollica M, et al. Nitric oxide in cancer metasta- sis[J]. Cancer Lett, 2014, 353(1) : 1-7. DOI: 10. 1016/j. canlet. 2014.07. 014.
  • 7Frederiksen LJ, Sullivan R, Maxwell LR, et al. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling[ J]. Clin Cancer Res, 2007, 13(7): 2199-2206. DOI: 10. 1158/1078-0432. CCR- 06-1807.
  • 8Li QC, Liang Y, Tian Y, et al. Arctigenin induces apoptosis in colon cancer cells through ROS/p38MAPK pathway [ J]. J BUON, 2016, 21(1): 87-94..
  • 9Serafim RA, Primi MC, Trossini GH, et al. Nitric oxide : state of the art in drug design[J]. Curr Med Chem, 2012, 19(3) : 386-405.
  • 10Basudhar D, Cheng RC, Bharadwaj G, et al. Chemotherapeutic po- tential of diazeniumdiolate-based aspirin prodrugs in breast cancer [J]. Free Radic Biol Med, 2015, 83(83): 101-114. DOI: 10. 1016/j. freeradbiomed. 2015.01. 029.

共引文献7

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部